Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism

Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism

Vall Hebron Institut de Recerca

Projects

European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Neurodegeneration as an early event in the Pathogenesis of Diabetic Retinopathy: A multicentric, prospective, phase II-III, open randomized controlled trial to assess the e

IP: Rafael Simó Canonge
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT15/00126
Duration: 01/01/2016 - 31/12/2016

MOPEAD: Models Of Patient Engagement for Alzheimer’s Disease

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: The Innovative Medicines Initiative
Funding: 79887.5
Reference: MOPEAD_IMI2015
Duration: 01/09/2016 - 31/12/2019

PRE-test-STROKE [Personalizing REperfusion Therapeutic Strategies in Stroke]

IP: Joan Montaner Villalonga
Collaborators: Eva Baldrich Rubio, Rafael Simó Canonge, Nuria Paz Torres Aguila
Funding agency: Instituto de Salud Carlos III
Funding: 836037.4
Reference: PMP15/00022
Duration: 01/01/2016 - 31/12/2019

Diabetis i Metabolisme (GRC)

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai, Lorena Ramos Pérez, Rosa Burgos Peláez, Olga Simó Servat, Patricia Bogdanov Baruj
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2014 SGR 270
Duration: 01/01/2014 - 31/12/2016